Jeffrey D Long Selected Research

Guanine

1/2021	Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's Disease.
1/2018	Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington's Disease.
1/2016	Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome.
12/2015	Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.
10/2015	Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
12/2014	Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
8/2014	WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease.
7/2013	Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey D Long Research Topics

Disease

22	Huntington Disease (Huntington's Disease) 01/2022 - 12/2011
4	Disease Progression 01/2021 - 01/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 07/2013
3	Obesity 01/2017 - 05/2009
2	Postpartum Depression (Post-Natal Depression) 01/2022 - 01/2019
2	Cognitive Dysfunction 01/2021 - 01/2021
2	Atrophy 01/2018 - 04/2014
2	Birth Weight (Birth Weights) 01/2009 - 01/2007
1	Heart Diseases (Heart Disease) 10/2021
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Headache (Headaches) 01/2018
1	Multiple Sclerosis 01/2018
1	Chronic Progressive Multiple Sclerosis 01/2018
1	Neoplasms (Cancer) 01/2017
1	Sleepiness 01/2017
1	Parkinson Disease (Parkinson's Disease) 07/2016
1	Movement Disorders (Movement Disorder) 07/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2012
1	Weight Gain 01/2009
1	Iron Deficiencies 01/2007
1	Diabetes Mellitus 01/2007
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2007

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
8	GuanineIBA 01/2021 - 07/2013
8	Adenine FDA LinkGeneric 01/2021 - 07/2013
8	CytosineIBA 01/2021 - 07/2013
6	Biological ProductsIBA 01/2022 - 07/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2012
2	IronIBA 01/2007 - 01/2007
1	Tuberculin (PPD)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2021
1	Tetrabenazine (Nitoman)FDA Link 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Vasopressins (Vasopressin)IBA 11/2020
1	SRX246IBA 11/2020
1	Complement System Proteins (Complement)IBA 04/2020
1	Sertraline (Zoloft)FDA LinkGeneric 01/2019
1	ibudilastIBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Cyclic NucleotidesIBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	24-hydroxycholesterolIBA 07/2013
1	8-Hydroxy-2'-DeoxyguanosineIBA 06/2012
1	Insulin (Novolin)FDA Link 01/2009
1	Ferritins (Ferritin)IBA 01/2007

Therapy/Procedure

5	Therapeutics 01/2018 - 04/2014
1	Activities of Daily Living (ADL) 07/2016
1	Bariatric Surgery 03/2011
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 05/2009
1	Enteral Nutrition (Feeding, Tube) 01/2009